4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-22-016027
CEO and Director bought 19,727 shares at $2.63 ($51,882)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meckler Jeffrey A CEO and Director | 2022-06-06 | Purchase | +19,727 | $2.63 | $51,882 | 45,374 | D |
| Open-market purchases · 19,727 sh · avg $2.63 · $51,882 | |||||||
Loading xslF345X03/ownership.xml…